Skip to main content
. 2021 Sep 18;2021:9221693. doi: 10.1155/2021/9221693

Table 3.

Comparative characteristics of patients with different degrees of lung damage.

CT0, 1 CT2 CT3,4
N 26 18 15
Age, y 64.5 [51.3; 71.8] 60.5 [53.0; 66.5] 57.0 [49.5; 63.5]
Sex, man (%) 18 (69%) 13 (72%) 15 (100%)
HHcy: tHcy > 10 μM (%) 4 (15%) 6 (33%) 6 (40%)
Arterial hypertension (%) 13 (50%) 6 (33%) 5 (33%)
Diabetes mellitus (%) 3 (12%) 2 (11%) 2 (13%)
Atherosclerosis (%) 9 (35%) 3 (17%) 5 (33%)
HGB (g/l) 140 [128; 161] 130 [120; 161] 147 [142; 149]
HCT (%) 42 [37; 45] 41 [36; 46] 42 [41; 43]
RBC (1012/l) 5.0 [4.3; 5.2] 5.0 [3.8; 5.3] 4.9 [4.5; 5.1]
PLT (109/l) 261 [216; 326] 237 [169; 286] 271 [214; 317]
WBC (109/l) 6.14 [4.68; 8.88] 5.2 [3.6; 5.9] 7.7 [4.1; 10.9]
ESR (mm/h) 34 [19; 52] 46 [27; 72] 82 [76; 86] ‡,£,,∗∗
D-dimer (mg/l) 0.93 [0.51; 1.53] 0.71 [0.46; 0.82] 1.23 [0.83; 1.53]
CRB (mg/l) 7.4 [1.8; 24.0] 38.9 [6.6; 56.0] 61.1 [32.0; 117]‡,,∗∗
IL-6 (ng/l) 4.85 [3.00; 18.5] 6.40 [3.48; 26.0] 13.97 [5.34; 50.6]
tGSH (μM) 1.81 [1.04; 2.34] 1.15 [0.85; 1.76] 1.22 [0.76; 1.42]
rCG (μM) 1.59 [1.31; 1.98] 1.30 [1.12; 1.78] 1.29 [1.08; 1.81]
AOPP (μM chloramine B equivalents) 39.7 [29.5; 53.2] 42.0 [30.0; 61.1] 47.1 [34.3; 71.8]

CT0, 1 vs. CT2-4, ∗∗CT0-2 vs. CT3,4, p < 0.05 compared with the “CT0,1” group. £p < 0.05 compared with the “CT2” group.